Publications by authors named "Alexis Bindzi Zoa"

Article Synopsis
  • - The study reviews the effectiveness of combining gemcitabine and erlotinib (Gem-Erlo) for pancreatic cancer treatment, noting mixed results from past randomized controlled trials (RCTs) regarding its benefits over standard chemotherapy.
  • - Comprehensive literature analysis included seven RCTs and 2,152 patients, focusing on various performance metrics such as disease control rate (DCR), overall survival (OS), and progression-free survival (PFS).
  • - Findings indicate that while Gem-Erlo enhances DCR, it does not significantly improve overall survival, progression-free survival, or response rate compared to gemcitabine alone.
View Article and Find Full Text PDF